Pharmaceutical Executive-03-17-2009
Advertisement
Advertisement
Trending on PharmExec
1
Vinay Prasad Out at CBER for Second Time in Under a Year
2
Ipsen Withdraws Tazverik from Market Due to Emerging Data from Clinical Trial
3
Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals
4
Novo Nordisk Signs Deal with Hims & Hers
5